Sarcoma  >>  ifosfamide  >>  Phase 1
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ifosfamide / Generic mfg.
NCT03283696: A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Completed
1b
24
Europe, US
Olaratumab, LY3012207, Doxorubicin, Ifosfamide, Mesna
Eli Lilly and Company
Soft Tissue Sarcoma
04/19
08/19
NCT00001209: A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

Completed
1
120
US
vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16
National Cancer Institute (NCI)
Neuroectodermal Tumor, Primitive, Neuroepithelioma, Osteosarcoma, Sarcoma, Sarcoma, Ewing's
 
08/00
NCT00030784: Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Completed
1
28
Europe
ifosfamide, pegylated liposomal doxorubicin hydrochloride
European Organisation for Research and Treatment of Cancer - EORTC
Sarcoma
03/05
 
NCT00358540: Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Completed
1
18
US
eltrombopag
GlaxoSmithKline
Thrombocytopaenia
10/10
10/10
NCT00960063: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Terminated
1
4
NA
Temozolomide, Vincristine, Ifosfamide, Irinotecan, Robatumumab, Doxorubicin, Cyclophosphamide, Etoposide
Merck Sharp & Dohme LLC
Neoplasms, Solid Tumors, Bone Cancer, Kidney Tumor, Neuroblastoma
12/10
12/10
NCT01258634: A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Terminated
1
2
US
Dexrazoxane, Doxorubicin, Cisplatin, G-CSF, PEG-filgrastim, Etoposide, Ifosfamide, Mesna, Leucovorin
University of Chicago
Osteosarcoma, Lung Metastases
11/11
11/11
NCT00742924: Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Completed
1
24
US, Canada, RoW
cisplatin, Cis-diamminedichloroplatinum II, CDDP, cis-DDP, Platinol-AQ, NSC #119875, dexrazoxane hydrochloride, ICRF-187, ADR-529, ZINECARD, NSC #169780, doxorubicin hydrochloride, Adriamycin, NSC #123127, etoposide, VePesid, Etopophos, VP-16, NSC #141540, ifosfamide, Isophosphamide, Iphosphamide, Z4942, Ifex, NSC #109724, leucovorin calcium, LCV, Wellcovorin, citrovorum factor, folinic acid, NSC #003590, methotrexate, MTX, amethopterin, Trexall, NSC #000740, zoledronic acid, 1-Hydroxy-2-imidazol-1-ylethylidene - diphosphonic acid, zoledronate, Zometa, Aclasta, NSC# 721517, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery, filgrastim, Granulocyte Colony-Stimulating Factor, r-metHuG-CSF, G-CSF, Neupogen, NSC #614629, Mesna, sodium 2-mercaptoethane sulfonate, UCB 3983, Mesnex, NSC #113891
Children's Oncology Group, National Cancer Institute (NCI)
Sarcoma
04/12
 
NCT00623077: MT2004-30: Tomotherapy for Solid Tumors

Terminated
1
23
US
filgrastim, G-CSF, Sargramostim, busulfan, Busulfex, Myleran, etoposide, Eposin, VP-16, ifosfamide, Mitoxana, Ifex, melphalan, Alkeran, thiotepa, stem cell transplantation, HPC infusion, tomotherapy, total marrow irradiation, Mesna, Uromitexan®, Mesnex, Whole lung radiation
Masonic Cancer Center, University of Minnesota
Brain and Central Nervous System Tumors, Kidney Cancer, Liver Cancer, Retinoblastoma, Sarcoma
07/12
10/16
NCT00822848: Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Checkmark P1 data-ASCO
Jun 2012 - Jun 2012: P1 data-ASCO
Completed
1
18
US
epirubicin hydrochloride, ifosfamide, sorafenib tosylate, immunoenzyme technique, immunohistochemistry staining method, laboratory biomarker analysis, adjuvant therapy, Adjuvant radiotherapy, Adjuvant chemotherapy, neoadjuvant therapy, Neoadjuvant chemoradiotherapy, therapeutic conventional surgery, hypofractionated radiation therapy
OHSU Knight Cancer Institute, National Cancer Institute (NCI)
Sarcoma
09/12
04/13
NCT00662233: Combination Chemotherapy in Treating Patients With Sarcoma

Completed
1
28
US
cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, vincristine sulfate, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery, brachytherapy, intraoperative radiation therapy, radiation therapy
Mayo Clinic, National Cancer Institute (NCI)
Ovarian Cancer, Sarcoma
10/13
10/13
ChiCTR1900027033: Phase I dose escalation study of liposome doxorubicin combined with ifosfamide in the treatment of advanced soft tissue sarcoma

Recruiting
1
36
 
liposome doxorubicin combined with ifosfamide
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, CSPC Ouyi Pharmaceutical Co., Ltd.
soft tissue sarcoma
 
 
ChiCTR1900028270: Phase I dose escalation research of liposomal doxorubicin combined with ifosfamide in the treatment of advanced soft tissue sarcoma

Not yet recruiting
1
18
 
Liposome adriamycin combined with ifosfamide
Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology; Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Shijiazhuang Pharmaceutical Group Co., Ltd.
sarcoma
 
 
NCT06156410: Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma

Recruiting
1
30
US
Cabozantinib
Children's Hospital of Philadelphia, Children's Hospital Colorado, Exelixis, Alex's Lemonade Stand Foundation
Ewing Sarcoma, Osteosarcoma
11/27
11/28
NCT04199026: Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Not yet recruiting
1
20
US
Doxorubicin, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Drug Delivery Microdevice, Microdevice, Everolimus, 42-O-(2-Hydroxy)ethyl Rapamycin, Afinitor, Certican, RAD 001, RAD001, Votubia, Zortress, Ganitumab, AMG 479, Anti-IGF-1R Human Monoclonal Antibody AMG-479, Ifosfamide, Asta Z 4942, Asta Z-4942, Cyfos, Holoxan, Holoxane, Ifex, IFO, IFO-Cell, Ifolem, Ifomida, Ifomide, Ifosfamidum, Ifoxan, IFX, Iphosphamid, Iphosphamide, Iso-Endoxan, Isoendoxan, Isophosphamide, Mitoxana, MJF 9325, MJF-9325, Naxamide, Seromida, Tronoxal, Z 4942, Z-4942, Irinotecan, Pazopanib, GW786034, Polyethylene Glycol, Glycol, polyethylene, PEG, Poly(oxyethylene), Polyethylene Glycol 400, Polyethylene Glycol 8000, POLYETHYLENE GLYCOL, UNSPECIFIED, Polyethylene Oxide, Temozolomide, CCRG-81045, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-, M & B 39831, M and B 39831, Methazolastone, RP-46161, SCH 52365, Temcad, Temodal, Temodar, Temomedac, TMZ, Temsirolimus, CCI-779, CCI-779 Rapamycin Analog, Cell Cycle Inhibitor 779, Rapamycin Analog, Rapamycin Analog CCI-779, Torisel, Therapeutic Conventional Surgery, Vincristine, LEUROCRISTINE, VCR, Vincrystine
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma
12/25
12/25

Download Options